Literature DB >> 21252229

REST regulates DYRK1A transcription in a negative feedback loop.

Mei Lu1, Lanlan Zheng, Bo Han, Luanluan Wang, Pin Wang, Heng Liu, Xiulian Sun.   

Abstract

DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) has been shown to be involved in learning and memory impairments in Alzheimer disease and Down syndrome. As a homolog of Drosophila minibrain gene, DYRK1A also plays important roles in neurodevelopment; however, the function and regulatory mechanism of DYRK1A in neurodevelopment remain elusive. REST (RE1 silencing transcription factor) plays vital roles in neuronal differentiation. Here, we found that REST can activate DYRK1A transcription via a neuron-restrictive silencer element at bp -833 to -815 of human DYRK1A promoter. The coordinated expression of DYRK1A and REST in mouse brain further supports the cross-interaction of DYRK1A and REST during neurodevelopment. Moreover, we showed that DYRK1A dosage imbalance reduced REST protein stability and transcriptional activity through facilitating ubiquitination and subsequent degradation of REST protein. Therefore, the regulation of DYRK1A by REST in a negative feedback loop suggests that DYRK1A and REST are closely related in neurodevelopment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252229      PMCID: PMC3060526          DOI: 10.1074/jbc.M110.174540

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome.

Authors:  Wieslaw K Dowjat; Tatyana Adayev; Izabela Kuchna; Krzysztof Nowicki; Sonia Palminiello; Yu Wen Hwang; Jerzy Wegiel
Journal:  Neurosci Lett       Date:  2006-12-04       Impact factor: 3.046

2.  The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.

Authors:  Ryo Kimura; Kouzin Kamino; Mitsuko Yamamoto; Aidaralieva Nuripa; Tomoyuki Kida; Hiroaki Kazui; Ryota Hashimoto; Toshihisa Tanaka; Takashi Kudo; Hidehisa Yamagata; Yasuharu Tabara; Tetsuro Miki; Hiroyasu Akatsu; Kenji Kosaka; Eishi Funakoshi; Kouhei Nishitomi; Gaku Sakaguchi; Akira Kato; Hideyuki Hattori; Takeshi Uema; Masatoshi Takeda
Journal:  Hum Mol Genet       Date:  2006-11-29       Impact factor: 6.150

3.  SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation.

Authors:  Thomas F Westbrook; Guang Hu; Xiaolu L Ang; Peter Mulligan; Natalya N Pavlova; Anthony Liang; Yumei Leng; Rene Maehr; Yang Shi; J Wade Harper; Stephen J Elledge
Journal:  Nature       Date:  2008-03-20       Impact factor: 49.962

4.  The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development.

Authors:  Ariadna Laguna; Sergi Aranda; María José Barallobre; Rima Barhoum; Eduardo Fernández; Vassiliki Fotaki; Jean Maurice Delabar; Susana de la Luna; Pedro de la Villa; Maria L Arbonés
Journal:  Dev Cell       Date:  2008-12       Impact factor: 12.270

5.  Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.

Authors:  Soo-Ryoon Ryoo; Hyun-Jeong Cho; Hye-Won Lee; Hey Kyeong Jeong; Chinzorig Radnaabazar; Yeun-Soo Kim; Min-Jeong Kim; Mi-Young Son; Hyemyung Seo; Sul-Hee Chung; Woo-Joo Song
Journal:  J Neurochem       Date:  2007-11-14       Impact factor: 5.372

6.  Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome.

Authors:  Fei Liu; Zhihou Liang; Jerzy Wegiel; Yu-Wen Hwang; Khalid Iqbal; Inge Grundke-Iqbal; Narayan Ramakrishna; Cheng-Xin Gong
Journal:  FASEB J       Date:  2008-05-28       Impact factor: 5.191

7.  DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine.

Authors:  Anne Seifert; Lindsey A Allan; Paul R Clarke
Journal:  FEBS J       Date:  2008-11-07       Impact factor: 5.542

8.  DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome.

Authors:  Claudia Canzonetta; Claire Mulligan; Samuel Deutsch; Sandra Ruf; Aideen O'Doherty; Robert Lyle; Christelle Borel; Nathalie Lin-Marq; Frederic Delom; Jürgen Groet; Felix Schnappauf; Serena De Vita; Sharon Averill; John V Priestley; Joanne E Martin; Janet Shipley; Gareth Denyer; Charles J Epstein; Cristina Fillat; Xavier Estivill; Victor L J Tybulewicz; Elizabeth M C Fisher; Stylianos E Antonarakis; Dean Nizetic
Journal:  Am J Hum Genet       Date:  2008-09-04       Impact factor: 11.025

9.  Characterization of the human DYRK1A promoter and its regulation by the transcription factor E2F1.

Authors:  Barbara Maenz; Paul Hekerman; Eva M Vela; Juan Galceran; Walter Becker
Journal:  BMC Mol Biol       Date:  2008-03-26       Impact factor: 2.946

10.  Control of chromosome stability by the beta-TrCP-REST-Mad2 axis.

Authors:  Daniele Guardavaccaro; David Frescas; N Valerio Dorrello; Angelo Peschiaroli; Asha S Multani; Timothy Cardozo; Anna Lasorella; Antonio Iavarone; Sandy Chang; Eva Hernando; Michele Pagano
Journal:  Nature       Date:  2008-03-20       Impact factor: 49.962

View more
  20 in total

1.  Phosphatase activity of small C-terminal domain phosphatase 1 (SCP1) controls the stability of the key neuronal regulator RE1-silencing transcription factor (REST).

Authors:  Nathaniel Tate Burkholder; Joshua E Mayfield; Xiaohua Yu; Seema Irani; Daniel K Arce; Faqin Jiang; Wendy L Matthews; Yuanchao Xue; Yan Jessie Zhang
Journal:  J Biol Chem       Date:  2018-09-14       Impact factor: 5.157

2.  A facile consensus ranking approach enhances virtual screening robustness and identifies a cell-active DYRK1α inhibitor.

Authors:  Maria E Mavrogeni; Filippos Pronios; Danae Zareifi; Sofia Vasilakaki; Olivier Lozach; Leonidas Alexopoulos; Laurent Meijer; Vassilios Myrianthopoulos; Emmanuel Mikros
Journal:  Future Med Chem       Date:  2018-10-16       Impact factor: 3.808

3.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome.

Authors:  Dean Nižetić; Jürgen Groet
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

Review 4.  The Beta Cell in Type 2 Diabetes.

Authors:  Ashley A Christensen; Maureen Gannon
Journal:  Curr Diab Rep       Date:  2019-08-09       Impact factor: 4.810

5.  Protective variant for hippocampal atrophy identified by whole exome sequencing.

Authors:  Kwangsik Nho; Sungeun Kim; Shannon L Risacher; Li Shen; Jason J Corneveaux; Shanker Swaminathan; Hai Lin; Vijay K Ramanan; Yunlong Liu; Tatiana M Foroud; Mark H Inlow; Ashley L Siniard; Rebecca A Reiman; Paul S Aisen; Ronald C Petersen; Robert C Green; Clifford R Jack; Michael W Weiner; Clinton T Baldwin; Kathryn L Lunetta; Lindsay A Farrer; Simon J Furney; Simon Lovestone; Andrew Simmons; Patrizia Mecocci; Bruno Vellas; Magda Tsolaki; Iwona Kloszewska; Hilkka Soininen; Brenna C McDonald; Martin R Farlow; Bernardino Ghetti; Matthew J Huentelman; Andrew J Saykin
Journal:  Ann Neurol       Date:  2015-02-14       Impact factor: 10.422

6.  Dyrk kinases regulate phosphorylation of doublecortin, cytoskeletal organization, and neuronal morphology.

Authors:  Tatiana I Slepak; Lindsey D Salay; Vance P Lemmon; John L Bixby
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-07

7.  HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.

Authors:  Ferdous Kadri; Marco Pacifici; Anna Wilk; Amanda Parker-Struckhoff; Luis Del Valle; Kurt F Hauser; Pamela E Knapp; Christopher Parsons; Duane Jeansonne; Adam Lassak; Francesca Peruzzi
Journal:  J Biol Chem       Date:  2015-11-03       Impact factor: 5.157

8.  Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc.

Authors:  Qiang Liu; Na Liu; Shaolei Zang; Heng Liu; Pin Wang; Chunyan Ji; Xiulian Sun
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

Review 9.  Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control.

Authors:  Walter Becker
Journal:  Cell Cycle       Date:  2012-08-23       Impact factor: 4.534

10.  RE1 silencing transcription factor (REST) negatively regulates ALL1-fused from chromosome 1q (AF1q) gene transcription.

Authors:  Yuanyuan Hu; Qianwen Sun; Chen Zhang; Qingquan Sha; Xiulian Sun
Journal:  BMC Mol Biol       Date:  2015-09-05       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.